Abstract
Diabetes complications increase with disease duration. No study was performed on the relationship between aortic stiffness and diabetes duration, taking into account the respective influence of such factors on macro- and microcirculation. In total, 618 subjects with type 2 diabetes (259 men) attending the Department of Internal Medicine of Tizi Ouzou Hospital (Algeria) were studied in collaboration with Hotel-Dieu Hospital (Paris, France). Brachial blood pressure (BP), anthropometric, clinical and biological data were evaluated. Aortic stiffness was estimated by carotid-femoral pulse wave velocity (PWV). From lower to higher tertile of diabetes duration, age, BP and PWV (10.1±2.7 to 12.3±2.8 m s−1) increased, while diabetes control and renal function worsened (all P<0.01). Diabetes duration was independently associated with PWV (R2=0.035, P<0.0001), even after adjustment for age, BP, heart rate, cardiovascular events and metabolic syndrome. Diabetes duration was significantly correlated to the prevalence of microalbuminuria (OR (95% CL) 1.3 (1.06–1.63), P=0.01), independently of age, sex, BP and renal function. Increased aortic stiffness was independently associated with the prevalence of cardiovascular events (P<0.001), reaching its maximal value above the first 2 years of diabetes duration. In conclusion, diabetes duration is an independent determinant of aortic stiffness in subjects with type 2 diabetes, representing about 4% of PWV variability. Diabetes duration is associated with microvascular complications independently of renal function, and with macrovascular complications through the presence of increased aortic stiffness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eckel RH . Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 2002; 105 (18): e138–e143.
Aoun S, Blacher J, Safar ME, Mourad JJ . Diabetes mellitus and renal failure: effects on large artery stiffness. J Hum Hypertens 2001; 15 (10): 693–700.
Lacy PS, O’Brien DG, Stanley AG, Dewar MM, Swales PPR, Williams B . Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004; 22 (10): 1937–1944.
Agnoletti D, Lieber A, Zhang Y, Protogerou AD, Borghi C, Blacher J et al. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis 2013; 230 (2): 315–321.
Fox CS, Sullivan L, D’Agostino RB, Wilson PWF . The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 2004; 27 (3): 704–708.
Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR . Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 2005; 165 (4): 430–435.
Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N . Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men. Arch Intern Med 2011; 171 (5): 404–410.
Brun E, Nelson RG, Bennett PH, Imperatore G, Zoppini G, Verlato G et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000; 23 (8): 1119–1123.
Kim Y, Shin M-S, Kim YS, Kang WC, Kim BR, Moon J et al. The impact of diabetes duration on left ventricular diastolic function and cardiovascular disease. Postgrad Med J 2012; 88 (1038): 189–193.
Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events the Framingham Heart Study. Circulation 2010; 121 (4): 505–511.
Van Dijk RAJM, Bakker SJL, Scheffer PG, Heine RJ, Stehouwer CDA . Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Invest 2003; 33 (4): 307–315.
Wadwa RP, Urbina EM, Anderson AM, Hamman RF, Dolan LM, Rodriguez BL et al. Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2010; 33 (4): 881–886.
Cardoso CRL, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF . Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009; 205 (2): 472–476.
Charvat J, Chlumsky J, Zakovicova E, Kvapil M . Common carotid artery intima-media thickness is not increased but distensibility is reduced in normotensive patients with type 2 diabetes compared with control subjects. J Int Med Res 2010; 38 (3): 860–869.
Lee J-I, Oh S-J, Ha W-C, Kwon H-S, Sohn T-S, Son H-S et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res Clin Pract 2012; 95 (1): 42–47.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002; 106 (25): 3143–3421.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461–470.
Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26 (3): 485–490.
Volpe M, Battistoni A, Tocci G, Rosei EA, Catapano AL, Coppo R et al. Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers. J Hypertens 2012; 30 (6): 1056–1064.
Verbeke F, Lindley E, Van Bortel L, Vanholder R, London G, Cochat P et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 2014; 29 (3): 490–496.
Salah Mansour A, Yannoutsos A, Majahalme N, Agnoletti D, Safar ME, Ouerdane S et al. Aortic stiffness and cardiovascular risk in type 2 diabetes. J Hypertens 2013; 31 (8): 1584–1592.
Cruickshank K . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106 (16): 2085–2090.
Naka KK, Papathanassiou K, Bechlioulis A, Kazakos N, Pappas K, Tigas S et al. Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol 2012; 11 (1): 127.
Teoh WL, Price JF, Williamson RM, Payne R a, Van Look L a F, Reynolds RM et al. Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. J Hypertens 2013; 31 (5): 1010–1017.
Aronson D . Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003; 21 (1): 3–12.
Yamagishi S . Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 2011; 46 (4): 217–224.
Safar ME, Plante GE, Mimran A . Arterial stiffness, pulse pressure, and the kidney. Am J Hypertens 2015; 28 (5): 561–569.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
AP has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number '299086 MMC FP7-PEOPLE-2011-IEF'. All the other authors declared no competing interest concerning this paper. No relation with industry was declared.
Rights and permissions
About this article
Cite this article
Agnoletti, D., Mansour, A., Zhang, Y. et al. Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus. J Hum Hypertens 31, 189–194 (2017). https://doi.org/10.1038/jhh.2016.58
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2016.58
This article is cited by
-
The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II
BMC Nephrology (2020)
-
Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis
Journal of Human Hypertension (2019)